Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Meningococcal meningitis
MeSH D008585 - meningococcal meningitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016920:
Bacterial meningitis
102 Companies
29 Drugs
$
Success rate
D008589:
Meningococcal infections
46 Companies
7 Drugs
$
Success rate
D008585:
Â
Meningococcal meningitis
35 Companies
9 Drugs
$
Success rate
D014884:
Waterhouse-friderichsen syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
100
%
1/1
Phase 3
67
%
4/6
Approved:
4
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Penicillin v
,
Ademetionine
,
Sodium chloride
,
Bevifimod
,
Fendrix
,
Menactra
,
Pneumovax
,
Prevenar
Sanofi
Edrecolomab
,
Aspartame
,
Bevifimod
,
Nimenrix
,
Fendrix
,
Gardasil
,
Menactra
,
Pcv13
,
Pneumovax
,
Ipv
,
Pcv
,
Prevenar
Allergan
Prednisolone
,
Prednisolone tebutate
Pfizer
Meropenem
,
Penicillin v
,
Polymyxin b
,
Sodium chloride
,
Aspartame
,
Fendrix
,
Menactra
Eli Lilly
Sulfadiazine
,
Sulfadiazine, silver
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use